Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes (Q45280485)

11 December 2017

title

Fluoroquinolone-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes (English)

1 reference

11 December 2017

main subject

Pseudomonas aeruginosa

0 references

author name string

Donald I Hsu

1

1 reference

11 December 2017

Mark P Okamoto

2

1 reference

11 December 2017

Rekha Murthy

3

1 reference

11 December 2017

Annie Wong-Beringer

4

1 reference

11 December 2017

language of work or name

English

0 references

publication date

22 February 2005

1 reference

Journal of Antimicrobial Chemotherapy

11 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

11 December 2017

volume

55

1 reference

11 December 2017

issue

4

1 reference

11 December 2017

page(s)

535-541

1 reference

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Antipseudomonal antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Antimicrobial-Drug Prescription in Ambulatory Care Settings, United States, 1992–2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Management of fluoroquinolone resistance in Pseudomonas aeruginosa--outcome of monitored use in a referral hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Antibiotic Therapy for Ambulatory Patients With Community-Acquired Pneumonia in an Emergency Department Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Reference group choice and antibiotic resistance outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

Trends in antimicrobial drug development: implications for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKI026

21 January 2018

Identifiers

DOI

10.1093/JAC/DKI026

1 reference

11 December 2017

1 reference